Online citations, reference lists, and bibliographies.

National Patterns In Antidepressant Medication Treatment.

M. Olfson, S. Marcus
Published 2009 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
CONTEXT Antidepressants have recently become the most commonly prescribed class of medications in the United States. OBJECTIVE To compare sociodemographic and clinical patterns of antidepressant medication treatment in the United States between 1996 and 2005. DESIGN Analysis of antidepressant use data from the 1996 (n = 18 993) and 2005 (n = 28 445) Medical Expenditure Panel Surveys. SETTING Households in the United States. PARTICIPANTS Respondents aged 6 years or older who reported receiving at least 1 antidepressant prescription during that calendar year. MAIN OUTCOME MEASURES Rate of antidepressant use and adjusted rate ratios (ARRs) of year effect on rate of antidepressant use adjusted for age, sex, race/ethnicity, annual family income, self-perceived mental health, and insurance status. RESULTS The rate of antidepressant treatment increased from 5.84% (95% confidence interval [CI], 5.47-6.23) in 1996 to 10.12% (9.58-10.69) in 2005 (ARR, 1.68; 95% CI, 1.55-1.81), or from 13.3 to 27.0 million persons. Significant increases in antidepressant use were evident across all sociodemographic groups examined, except African Americans (ARR, 1.13; 95% CI, 0.89-1.44), who had comparatively low rates of use in both years (1996, 3.61%; 2005, 4.51%). Although antidepressant treatment increased for Hispanics (ARR, 1.75; 95% CI, 1.60-1.90), it remained comparatively low (1996, 3.72%; 2005, 5.21%). Among antidepressant users, the percentage of patients treated for depression did not significantly change (1996, 26.25% vs 2005, 26.85%; ARR, 0.95; 95% CI, 0.83-1.07), although the percentage of patients receiving antipsychotic medications (5.46% vs 8.86%; ARR, 1.77; 95% CI, 1.31-2.38) increased and those undergoing psychotherapy declined (31.50% vs 19.87%; ARR, 0.65; 95% CI, 0.56-0.72). CONCLUSIONS From 1996 to 2005, there was a marked and broad expansion in antidepressant treatment in the United States, with persisting low rates of treatment among racial/ethnic minorities. During this period, individuals treated with antidepressants became more likely to also receive treatment with antipsychotic medications and less likely to undergo psychotherapy.
This paper references
10.1089/CAP.2005.15.26
Trends in use of antidepressants, lithium, and anticonvulsants in Kaiser Permanente-insured youths, 1994-2003.
E. Hunkeler (2005)
10.1056/NEJMSA043266
Prevalence and treatment of mental disorders, 1990 to 2003.
R. Kessler (2005)
10.1001/JAMA.288.16.2052
Goodman and Gilman's The Pharmacological Basis of Therapeutics
M. Casavant (2002)
National Ambulatory Medical Care Survey: 2006 summary.
D. Cherry (2008)
10.1176/appi.ajp.2007.05081484
The prospective course of rapid-cycling bipolar disorder: findings from the STEP-BD.
Christopher D. Schneck (2008)
Sample Design of the Medical Expenditure Panel Survey Household Component, 1998–2007
TM Ezzati-Rice (2008)
10.1056/NEJMOA064135
Effectiveness of adjunctive antidepressant treatment for bipolar depression.
G. Sachs (2007)
10.1176/PN.40.17.00400001
New Data Show Declines In Antidepressant Prescribing
Jim Rosack (2005)
10.1056/NEJMOA052963
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
A. Rush (2006)
10.1037/H0087736
Racial differences in attitudes toward professional mental health care and in the use of services.
C. Diala (2000)
10.1097/01.MLR.0000053228.58042.E4
The Acceptability of Treatment for Depression Among African-American, Hispanic, and White Primary Care Patients
L. Cooper (2003)
National Ambulatory Medical Care Survey: 2005 summary.
D. Cherry (2007)
10.1002/SIM.2809
On modelling response propensity for dwelling unit (DU) level non-response adjustment in the Medical Expenditure Panel Survey (MEPS).
L. Wun (2007)
Design and Methods of the Medical Expenditure Panel Survey Household Component
J. Cohen (1997)
10.1046/j.1525-1497.2000.08035.x
Treatment preferences among depressed primary care patients
M. Dwight-Johnson (2007)
10.1093/milmed/151.1.386
Goodman and Gilman's the Pharmacological Basis of Therapeutics
W. Stigelman (1986)
10.1176/ps.2006.57.4.472
Patterns of adult psychotherapy in psychiatric practice.
Joshua E. Wilk (2006)
10.4088/JCP.V68N0607
Provider and patient characteristics associated with antidepressant nonadherence: the impact of provider specialty.
K. Bambauer (2007)
10.1001/ARCHINTE.165.21.2497
Impact of antidepressant drug adherence on comorbid medication use and resource utilization.
W. Katon (2005)
10.1159/000112885
Increase in Antidepressant Medication in the US Adult Population between 1990 and 2003
R. Mojtabai (2008)
10.1097/MLR.0b013e3180ca95d3
National Trends in Ethnic Disparities in Mental Health Care
C. Blanco (2007)
Management of fibromyalgia syndrome.
D. Goldenberg (1989)
10.1176/AJP.155.1.1
ECT, research, and professional ambivalence.
C. Salzman (1998)
10.1377/HLTHAFF.24.1.195
Prescription drugs and the changing patterns of treatment for mental disorders, 1996-2001.
S. Zuvekas (2005)
Design and estimation strategies in the Medical Expenditure Panel Survey for investigating trends in health care expenditures
T Ezzati-Rice (2004)
The Expert Consensus Guideline Series. Treatment of depression in women.
L. Altshuler (2001)
10.13016/9DQU-NQNA
Income, Poverty, and Health Insurance Coverage in the United States: 2004
Carmen DeNavas-Walt (2004)
10.1097/00019048-200202000-00025
PROMOTION OF PRESCRIPTION DRUGS TO CONSUMERS
RNST (2002)
The Carter Center Mental Health Program: Addressing the Public Health Crisis in the Field of Mental Health Through Policy Change and Stigma Reduction
Rebecca G. Palpant (2006)
Consensus statement on social anxiety disorder from the International Consensus Group on Depression and Anxiety.
J. Ballenger (1998)
STAR*D Study Team. Buproprion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression
AJ Rush (2006)
10.1176/APPI.PS.54.12.1582
Economic grand rounds: financial disincentives for the provision of psychotherapy.
J. West (2003)
Suicidality in children and adolescents being treated with antidepressant medications
J Rosack (2007)
10.1016/J.GENHOSPPSYCH.2003.12.001
Patients' preferences in the treatment of depressive disorder in primary care.
D. V. van Schaik (2004)
10.1377/HLTHAFF.22.5.8
Is the prevalence of mental disorders a good measure of the need for services?
D. Mechanic (2003)
10.1371/journal.pmed.0050045
Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration
I. Kirsch (2008)
10.1002/PDS.1367
Trends in psychotropic medication use among U.S. adults.
Ryne Paulose-Ram (2007)
10.1097/01.CHI0000219828.70483.C5
Risk perception research and the black box warning for SSRIs in children.
R. Marshall (2006)
Background information and treatment recommendations for patients with HIV/AIDS
J. Atkinson (2000)
10.1056/NEJMC051936
Prevalence and treatment of mental disorders.
T. Mackenzie (2005)
10.1016/J.JADOHEALTH.2005.07.012
Depression treatment during outpatient visits by U.S. children and adolescents.
J. Ma (2005)
10.1176/AJP.2006.163.12.2141
Changes in the prevalence of major depression and comorbid substance use disorders in the United States between 1991-1992 and 2001-2002.
W. Compton (2006)
Estimation procedures in the 1996 Medical Expenditure Panel Survey Household Component.
Cohen Sb (1999)
10.1001/JAMA.279.7.526
Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties.
H. Pincus (1998)
10.1016/J.JAD.2007.04.022
Depressive symptoms and antidepressant use in a random community sample of ethnically diverse, urban elder persons.
M. Grunebaum (2008)
Advisory
FDA Public Healt (2008)
10.1097/01.CHI.0000192249.61271.81
National estimates of antidepressant medication use among U.S. children, 1997-2002.
B. Vitiello (2006)
10.4088/JCP.V61N0105
Racial variation in antidepressant treatment in a Medicaid population.
C. Melfi (2000)
10.1176/ps.2008.59.1.72
Improving medication management of depression in health plans.
Constance M. Horgan (2008)
10.1001/JAMA.289.23.3095
The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).
R. Kessler (2003)
10.1056/NEJMSA070502
A decade of direct-to-consumer advertising of prescription drugs.
J. Donohue (2007)
10.4065/82.4.518
Impact of the FDA black box warning on physician antidepressant prescribing and practice patterns: opening Pandora's suicide box.
T. Lineberry (2007)
10.1001/archpsyc.65.8.962
National trends in psychotherapy by office-based psychiatrists.
R. Mojtabai (2008)
10.1377/HLTHAFF.19.4.165
Increasing use of new prescription drugs: a case study.
S. Foote (2000)
10.1007/s10742-006-0006-z
The impact of survey attrition on health insurance coverage estimates in a National Longitudinal Health Care Survey
S. Cohen (2006)
Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety.
J. Ballenger (2001)
10.1097/YIC.0b013e3282f2b3dd
Ethnicity/race and the diagnosis of depression and use of antidepressants by adults in the United States
D. Sclar (2008)
10.2165/00023210-200620080-00002
Overuse of Antidepressant Drugs for the Treatment of Depression
J. Jureidini (2006)
10.1111/j.1475-6773.2007.00770.x
Testing for statistical discrimination by race/ethnicity in panel data for depression treatment in primary care.
T. McGuire (2008)
10.1016/J.JAD.2007.10.016
Treatment of bipolar depression: an update.
K. Fountoulakis (2008)
10.1176/PS.2007.58.12.1533
Measuring trends in mental health care disparities, 2000 2004.
B. Cook (2007)
10.1176/PS.2009.60.3.306
Changing perceptions of depression: ten-year trends from the general social survey.
M.P.H. Kate H. Blumner (2009)
Practice guideline for the treatment of patients with eating disorders (revision)
C. Bell (2000)
Safety and tolerability of emerging pharmacological treatments for
DL Dunner (2005)
10.1056/NEJMsa065779
Selective publication of antidepressant trials and its influence on apparent efficacy.
E. Turner (2008)
10.1176/PS.2007.58.5.642
Americans' attitudes toward mental health treatment seeking: 1990-2003.
R. Mojtabai (2007)
10.1111/J.1399-5618.2005.00235.X
Safety and tolerability of emerging pharmacological treatments for bipolar disorder.
D. Dunner (2005)



This paper is referenced by
10.1177/1077558710388290
Does Depression Screening Have an Effect on the Diagnosis and Treatment of Mood Disorders in General Medical Settings? An Instrumental Variable Analysis of the National Ambulatory Medical Care Survey
Ramin Mojtabai (2011)
10.1080/1551806X.2013.827077
Psychoanalysis and the 21st Century: A Critique and a Vision
Kenneth A. Frank (2013)
Accroissement de la prévalence du TDA/H, de la consommation de psychostimulants et des symptômes dépressifs : l’importance du contexte social évaluée à partir des effets d’âge, de période et de cohorte
Marie-Christine Brault (2012)
IDI trends in antidepressant dispensing to New Zealand children and young people between 2007/08 and 2015/16.
Nicholas Bowden (2019)
10.1016/J.CHILDYOUTH.2018.09.004
Adolescent depression and the use of services and psychotropic medications in relation to family structure and race/ethnicity
Saijun Zhang (2018)
10.1186/1471-2431-11-40
Antidepressant and antipsychotic use in an Italian pediatric population
A. Clavenna (2011)
10.1007/s11920-014-0451-2
Adjustment Disorder: New Developments
P. Casey (2014)
10.14264/uql.2018.51
The overweight/obesity - depression links over the life course
M. Mannan (2017)
10.1177/0004867412466595
Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011
Chris P Stephenson (2013)
10.1111/bcp.13498
Association between antidepressant medication use and epithelial ovarian cancer risk: a systematic review and meta‐analysis of observational studies
Y. Huo (2018)
10.1016/j.psyneuen.2016.08.020
Longitudinal association of antidepressant medication use with metabolic syndrome: Results of a 9-year follow-up of the D.E.S.I.R. cohort study
M. Silva (2016)
10.1016/j.ajog.2016.01.170
The effect of antidepressants on fertility.
Marianne M. Casilla-Lennon (2016)
10.1016/j.ajo.2014.03.006
Selective serotonin reuptake inhibitor use and increased risk of cataract surgery: a population-based, case-control study.
J. Erie (2014)
10.1002/cncr.26603
Is screening effective in detecting untreated psychiatric disorders among newly diagnosed breast cancer patients?
S. Palmer (2012)
10.1007/s11920-012-0284-9
Clinically Significant Psychotropic Drug-Drug Interactions in the Primary Care Setting
B. English (2012)
10.1111/jgs.14936
Bone Turnover with Venlafaxine Treatment in Older Adults with Depression
K. Rawson (2017)
The Association between Obesity-Insulin Resistance and Depression-Anxiety: One Center, Cross-Sectional Study Obezite ve Insülin Direnci ile Depresyon ve Anksiyete Arasindaki İlişki: Tek Merkezli Kesitsel Çalişma
Esma Güldal (2015)
10.1016/j.jad.2014.11.009
Beliefs of people taking antidepressants about the causes of their own depression.
J. Read (2015)
10.1155/2019/4290207
Pitfalls in Geriatric Prescribing: Antidepressants and Extreme Sedation
Hirofumi Namiki (2019)
Utilizing Consumer Health Posts for Pharmacovigilance: Identifying Underlying Factors Associated with Patients’ Attitudes Towards Antidepressants
Maryam Zolnoori (2017)
10.1001/jamanetworkopen.2018.3750
Association of Focused Medication Review With Optimization of Psychotropic Drug Prescribing
R. Sheehan (2018)
The Use and Misuse of Psychiatric Drugs: An Evidence-Based Critique
Joel Paris (2010)
10.1007/978-1-4614-6419-8_25-1
Provision of Health Services: Mental Health Care
Jon Cylus (2018)
10.1053/j.ajkd.2011.12.033
Factors associated with depressive symptoms and use of antidepressant medications among participants in the Chronic Renal Insufficiency Cohort (CRIC) and Hispanic-CRIC Studies.
M. Fischer (2012)
10.1177/2158244014554204
Talking Circles for Adolescent Girls in an Urban High School
A. Schumacher (2012)
10.1037/14526-000
Forgiveness Therapy : An Empirical Guide for Resolving Anger and Restoring Hope
R. Enright (2014)
10.1017/S0033291717001301
Autism risk following antidepressant medication during pregnancy
A. Viktorin (2017)
10.5455/pcp.20200221095546
Comparison of Drugs Prescribed by Psychiatrists and Child/Adolescent Psychiatrists
V. Aydin (2020)
10.1891/1559-4343.13.1.6
STAR*D: A Tale and Trail of Bias
H. Pigott (2011)
10.1111/jgs.12945
Depression, Antidepressants, and Bone Health in Older Adults: A Systematic Review
Marie Anne Gebara (2014)
10.1017/S1461145711000745
Increase of antipsychotic medication in depressive inpatients from 2000 to 2007: results from the AMSP International Pharmacovigilance Program.
A. Konstantinidis (2012)
10.1016/j.pop.2016.01.002
Psychopharmacology in Primary Care Settings.
Joseph J Benich (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar